Annual Report & Accounts and Notice of AGM

RNS Number : 8796T

Epistem Holdings plc

26 November 2013

 



Epistem Plc

("Epistem" or "the Company")

2013 Annual Report & Accounts and Notice of AGM

Epistem confirms that the 2013 Annual Report & Accounts and Notice of the Annual General Meeting to be held at 11.00am on Wednesday, 18^th December 2013 at The Furniture Makers' Hall, 12 Austin Friars, London EC2N 2HE have been posted to shareholders. Copies of these documents can be found on the Company's website (www.epistem.co.uk)  

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                                [phone]

John Rylands, Financial Director                                                [phone]

Peel Hunt LLP

James Steel / Vijay Barathan                                                      [phone]

Mike Wort/Anna Dunphy                                                          [phone]

Walbrook PR

Notes to Editors:

About Epistem

Epistem is a biotechnology and personalised medicine company commercialising its expertise in epithelial stem cells and pharmacogenomics in the areas of oncology, gastrointestinal, dermatological and infectious disease.

Epistem develops innovative therapeutics, biomarkers and diagnostics alongside providing preclinical services to drug development companies. Epistem's core expertise is focused on the regulation of adult stem cells located in epithelial tissue which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. Epistem also has a range of proprietary amplification (RNA and DNA) technologies for use in drug discovery, development and diagnostics.

 

END

 

 

MSCNKPDBABDDPDB